Ozet A, Arpaci F, Yilmaz MI, Ayta H, Oztürk B, Kömürcü S, Yavuz AA, Tezcan Y, Açıkel C. Effects of Tamoxifen on Serum Leptin Level in Patients with Breast Cancer. Jpn J Clin Oncol, 31(9): 424-427, (2001). Ozata M, Avcu F, Durmuş O, Yilmaz MI, Ozdemir C, Yalcin A. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obes Res, 9(10):627-30, (2001). Saglam K, Yilmaz MI, Saglam A, Ulgey M, Bulucu F, Baykal Y . The Levels of Circulating Intercellular Adhesion Molecule-1 in Patients with Behçet’s Disease. Rheumatol Int,21(4):146-8, (2002). Saglam K, Serçe AF, Yilmaz MI, Bulucu F, Aydın A, Akay C, Sayal A Trace elements and antioxidant enzymes in Behcet's disease. Rheumatol Int, 22(3):93-6, (2002). Arpacı F, Yilmaz MI, Ozet A, Ayta H, Öztürk B, Kömürcü Ş, Özata M. Low serum leptin level in colon cancer patients without significant weight loss. Tumori 88(2):147-9, (2002). Ozata M, Durmuş O, Yilmaz MI, Bolu E, Erdoğan M, Özdemir Ç.The renin-angiotensin-aldosterone system (RAAS) and its relation with calcium homeostasis in male obesity. Med Sci Monit, 8(6):CR430-7, (2002). Yasar M, Mas MR,. Cömert B, Akay C, Deveci S, Yilmaz MI, Koçer B, Mas N, Doruk H, Koçar IH. Has the oxidative stress a role in late phase of experimental acute necrotizing pancreatitis? Hepatogastroenterology, 49(48):1692-5, (2002). Ural AU, Yilmaz MI, Avcu F,Yalçın A. Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components. Int J Hematology,76(3):279-283, (2002). Saglam K, Polat Z, Yilmaz MI, Gulec M, Akinci SB. Effects of Postmenopausal Hormone Replacement Therapy on Insulin Resistance. Endocrine, 18(3): 211–214, (2002). Özata M, Mergen M, Öktenli C, Aydın A, Sanisoğlu Y, Bolu E, Yilmaz MI, Sayal A, Işımer A, Özdemir Ç.Increased oxidative stress and hypozincemia in male obesity. Clin Biochem, 35(8):627–31, (2002). Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003 May;22(2):99–101. Saglam K, Kilic R, Yilmaz MI, Gulec M, Baykal Y, Kutlu M. Insulin resistance in patients with steatohepatitis. Hepatogastroenterology, 50(50):456–9, (2003). Cetin T, Arpaci F, Ozet A, Ozturk B, Komurcu S, Ihsan Uzar A, Yilmaz MI, Beyzadeoglu M, Oysul K, Ataergin S, Kuzhan O, Pekel A. Stem cell mobilization by G-CSF in solid and hematological malignancies: single daily dose is better than split dose in obese patients. J Clin Apheresis,18(3):120–4, (2003). Koc B, Erten V, Yilmaz MI, Sonmez A, Kocar IH. The relationship between red blood cell Na/K-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus. Endocrine, 21(3):273–8, (2003). Baykal Y, Yilmaz MI, Celik T, Gok F, Rehber H, Akay C, Kocar IH. Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens, 21(6):1207–11, (2003). Sonmez A, Baykal Y, Kilic M, Yilmaz MI, Saglam K, Bulucu F, Kocar IH. Fluvastatin improves insulin resistance in nondiabetic dyslpidemic patients. Endocrine, 22(2):151–4, (2003). Ural AU, Yilmaz MI, Avcu F, Pekel A, Zerman M, Nevruz O, Sengul A, Yalcin A. The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide. Int J Hematol, 78(5):443–9, (2003). Saglam K, Aydur E, Yilmaz MI, Göktaş S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol, 169(4):1308–11, (2003). Koc B, Aymelek S, Sonmez A, Yilmaz MI, Kocar H. Increased sucrose permeability in Behcet's disease. Rheumatol Int, 24(6):347–50, (2004). Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI. Antiannexin V autoantibody in thrombophilic Behcet's disease. Rheumatol Int, 24(2):77–9, (2004). Cetin T, Arpaci F, Yilmaz MI, Saglam K, Ozturk B, Komurcu S, Gunay M, Ozet A, Akay C, Kilic S, Ulutin C. Oxidative stress in patients undergoing high-dose chemotherapy plus peripheral blood stem cell transplantation. Biol Trace Elem Res, 97(3):237–47, (2004) Tüm Hekimlerimiz